Drug Profile
BMOV
Alternative Names: bis(maltolato)oxavanadium(IV)Latest Information Update: 27 Feb 2008
Price :
$50
*
At a glance
- Originator University of British Columbia
- Developer Gho Pharma; University of British Columbia
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Burns; Type 2 diabetes mellitus
Most Recent Events
- 02 Apr 2007 No development reported - Phase-II for Burns in Europe (IV)
- 02 Apr 2007 No development reported - Phase-II for Burns in USA (IV)
- 19 May 2003 No development reported - Preclinical for Type-2 diabetes mellitus in Canada (PO)